AI Platforms Reshaping Clinical Trial Protocol Design

Telperian Virtual Trial Simulator and Unlearn AI digital twins platforms lead recent advances in endpoint simulation and regulatory alignment for clinical trials. These biotech focused tools process natural language inputs into decision paths that yield simulated cohorts and compliance metrics.

Telperian Virtual Trial Simulator Decision OS

Operators input protocol narratives in everyday language describing study aims, patient traits, and outcome goals. Core engine parses text to extract design variables like sample size, stratification rules, endpoint definitions, and dropout projections. Multimodal fusion layer ingests historical trial records, real world evidence datasets, and statistical priors to build baseline models. Simulation kernel runs parallel scenarios varying power assumptions, event rates, and interim analysis triggers. Output generates probability of success curves per arm and subgroup alongside operational flags for regulatory risks such as deviant visit schedules. Generative module proposes endpoint tweaks benchmarked against precedent trials to boost statistical confidence while flagging FDA scrutiny points from agency guidances. Stack integrates emulated data generators with visualization exporters for protocol briefs ensuring reproducible designs before IRB submission.

Unlearn AI Digital Twins Decision OS

Teams enter protocol descriptions via natural language covering inclusion exclusion criteria, endpoint measures, and cohort constraints. Parsing system structures inputs into parametric models of trial dynamics. Fusion component harmonizes clinical trial archives and real world datasets into transparent benchmarks for population traits and endpoint distributions. Scenario builder iterates designs testing sample sizes, eligibility rules, and power tradeoffs with linked evidence traces. Digital twin generator crafts AI forecasts mimicking control arm outcomes from fused historical data reducing variability in effect detection. Regulatory scorer computes alignment via explainable metrics on assumption validity and design feasibility against FDA expectations. Generative suggestions refine endpoints drawing from multimodal trial data to optimize smaller cohorts or heightened power without patient matching reliance. Full stack delivers reproducible comparisons supporting protocol finalization with evidence backed tradeoffs.